Four-year outcome of aflibercept administration using a treat-and-extend regimen in eyes with recurrent neovascular age-related macular degeneration
Yuma Tsunekawa, Keiko Kataoka, Keiko Asai, Yasuki Ito, Hiroko Terasaki
Topics & Concepts
AfliberceptMedicineMacular degenerationVisual acuityRegimenOphthalmologyRanibizumabRetrospective cohort studyChoroidal neovascularizationSurgeryBevacizumabChemotherapyRetinal Diseases and TreatmentsOphthalmology and Visual Impairment StudiesRetinal Imaging and Analysis